762 results
·
8ms
·
Sources: EU EUDAMED, US FDA
Gastric proteogen 2 (PG II) Detection Kit(CLIA)
Device
EU IVDD
·
Eu Ivd General
·Shenzhen Zijian Biotechnology Co., Ltd·On the market
Gastric proteogen 1 (PG I) Detection Kit(CLIA)
Device
EU IVDD
·
Eu Ivd General
·Shenzhen Zijian Biotechnology Co., Ltd·On the market
IRTA1 (QM005)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
Inhibin alpha (QR088)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
Inhibin alpha (QR088)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
Inhibin alpha (QR088)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
Inhibin alpha (QR088)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
Inhibin alpha (QR088)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
Inhibin alpha (QR088)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
Inhibin alpha (QR088)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
IgG4 (QR092)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
IgG4 (QR092)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
IgG4 (QR092)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
IgG4 (QR092)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
IgG4 (QR092)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
IgG4 (QR092)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
IgG4 (QR092)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
IgA (QR050)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
IgA (QR050)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
IgA (QR050)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market